Ionis Pharmaceuticals (IONS) PT Raised to $87 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Chad Messer raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $87.00 (from $82.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
